Astellas Pharma Inc. Share Price Deutsche Boerse AG
Stocks
YPH
JP3942400007
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
01:10:29 11/09/2026 am IST
|
Pre-market 11:21:17 am | |||
| 11.90 EUR | -1.65% |
|
12.50 | +5.04% |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 01/09 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 3,99300Cr 2.59TCr 2.23TCr 2.1TCr 1.92TCr 3.58TCr 2,47900Cr 3.61TCr 25TCr 9.64TCr 1,25700Cr 9.73TCr 9.52TCr | P/E 2027 * |
10.7x | P/E 2028 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3,93400Cr 2.55TCr 2.2TCr 2.07TCr 1.89TCr 3.53TCr 2,44200Cr 3.56TCr 25TCr 9.5TCr 1,23900Cr 9.59TCr 9.38TCr | EV / Sales 2027 * |
1.69x | EV / Sales 2028 * | 1.63x |
| Free-Float |
98.88% | Yield 2027 * |
3.61% | Yield 2028 * | 3.74% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
Tradegate
| YPH | Real-time | |
|
OTC Markets
| ALPMF | Delayed | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed | |
|
Boerse Muenchen
| YPH | Real-time |
Last Transcript : Astellas Pharma Inc.
| 1 day | +5.04% | ||
| 1 week | -9.85% | ||
| Current month | -4.03% | ||
| 1 month | -4.03% | ||
| 3 months | +0.85% | ||
| 6 months | -9.78% | ||
| Current year | +6.92% |
| 1 week | 11.9 |  | 12.6 |
| 1 month | 11.9 | | 13.3 |
| Current year | 11 | | 14.19 |
| 1 year | 8.56 | | 14.19 |
| 3 years | 7.53 | | 14.19 |
| 5 years | 7.53 | | 16 |
| 10 years | 7.53 | | 16.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 01/06/2019 |
| Director/Board Member | 59 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.65% | -9.85% | - | - | 2.59TCr | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,00100Cr | |
| -0.27% | -4.34% | +51.52% | +65.89% | 64TCr | |
| +1.63% | -2.00% | +20.49% | +71.12% | 45TCr | |
| -0.63% | -3.09% | +29.84% | +34.59% | 34TCr | |
| +0.43% | -14.61% | +11.32% | +27.26% | 26TCr | |
| +0.93% | -3.19% | -1.31% | +8.41% | 25TCr | |
| -2.25% | -13.88% | +37.33% | +47.43% | 21TCr | |
| -0.90% | -5.06% | -18.47% | -57.75% | 20TCr | |
| -0.58% | -4.24% | +25.65% | +90.54% | 18TCr | |
| Average | +0.40% | -5.53% | +22.80% | +42.11% | 39.18TCr | |
| Weighted average by Cap. | +0.12% | -4.65% | +31.95% | +57.17% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,32900Cr 1.51TCr 1.3TCr 1.23TCr 1.12TCr 2.09TCr 1,44600Cr 2.11TCr 15TCr 5.62TCr 73TCr 5.68TCr 5.55TCr | 2,15500Cr 1.4TCr 1.2TCr 1.14TCr 1.03TCr 1.93TCr 1,33800Cr 1.95TCr 14TCr 5.2TCr 68TCr 5.25TCr 5.14TCr |
| Net income | 36TCr 230.99Cr 198.65Cr 187.43Cr 170.75Cr 319.19Cr 22TCr 322.09Cr 2.23TCr 859.12Cr 11TCr 867.41Cr 848.44Cr | 33TCr 215.88Cr 185.66Cr 175.17Cr 159.58Cr 298.32Cr 21TCr 301.02Cr 2.09TCr 802.93Cr 10TCr 810.68Cr 792.95Cr |
| Net Debt | -5.92TCr -38Cr -33Cr -31Cr -28Cr -53Cr -3.67TCr -54Cr -371.29Cr -142.9Cr -1.86TCr -144.28Cr -141.12Cr | -48TCr -312.05Cr -268.37Cr -253.21Cr -230.67Cr -431.21Cr -30TCr -435.13Cr -3.02TCr -1.16TCr -15TCr -1.17TCr -1.15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | €11.90 | -1.65% | 0 |
| 09/26/09 | €12.10 | -1.63% | 0 |
| 08/26/08 | €12.30 | -2.38% | 0 |
| 07/26/07 | €12.60 | -2.33% | 0 |
| 04/26/04 | €12.90 | -2.27% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- YPH Stock
Select your edition
All financial news and data tailored to specific country editions
